Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

Published January 2026

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms.

Although much of my professional experience has focused on the human microbiome, I have always had an interest in the soil and plant microbiome. What amazes me is the diversity of microorganisms present in the soil, which is surprisingly much higher than that of the human gut. Many of these microorganisms remain uncharacterised, and their potential for biotechnology and, more specifically, agricultural innovation is vast. Soil microorganisms and products derived therefrom can be exploited for numerous applications, including improving crop resilience, developing microbial-based fertilisers, assessing soil health, and predicting crop yields.

Numerous research initiatives, funded by public institutions such as Defra, BBSRC or UKRI, have been launched in the UK in the past few years. One of these, the five-year UK Crop Microbiome Cryobank project initiated in 2020 and involving Rothamsted Research, CABI, the James Hutton Institute and the John Innes Centre, aimed to create a comprehensive soil microbiome resource for both academic research and commercial development. The project focused on the physical preservation of diverse microorganisms isolated from crops and also led to the establishment of the public database AgMicrobiomeBase, which collates associated genomic and metagenomic data.

Another example is the TRUTH Project (Thriving Roots Underpinning Total Soil Health) is developing tools to measure and manage soil and root health. The project involves farmer-led soil microbiome data collection and aims to develop in-field soil health sensors using microbial diversity data.

A recent collaboration between the Earlham Institute and Quadram Institute, OpenLAND, is investigating the role of soil microbial communities in carbon storage as part of the UK’s commitment to reach its net-zero climate targets.

Of note, part of the new Microbiome Innovation Network (Microbiome-Net) funded by the BBSRC will support projects focusing on agricultural sustainability.

These initiatives demonstrate a coordinated national effort to position the UK as a hub for soil microbiome research.

The private sector is also showing a strong interest in soil microbiome innovation. For example, UK-based startup Elaniti has recently secured private investments to accelerate the development of its predictive platform linking soil microbiome data to crop performance.

With growing public and private investment, the UK offers an exceptional environment for soil microbiome innovation and for translating these discoveries into commercially valuable products and solutions. However, to fully capitalize on this opportunity, soil microbiome innovators must also understand how to protect their inventions and develop a robust IP strategy.

Later this year, we will publish a follow-up article exploring how IP relating to soil microbiome inventions can be protected and providing insight into IP strategy considerations for biotech companies in this field. Keep an eye on this page for updates.

For now, it is clear that the plant and soil microbiome represent an invaluable source for agricultural innovation and that the UK provides both the scientific expertise and a supportive ecosystem to transform this potential into impactful results.


This article was written by Trainee Patent Attorney Delphine Lauté-Caly.

Latest updates

Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details
Event - 15th December 2026

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Event details
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article
Event - 28th October 2026

HGF Attending the KINPA Conference 2026

HGF is pleased to be attending the KINPA Conference 2026, taking place on 28 October in Seoul, South Korea. Recognised as Korea’s largest intellectual property gathering, the conference brings together …

Event details
Event - 17th - 19th November 2026

HGF Attending IPBC Asia 2026

HGF is pleased to announce that Partner, Dr Jennifer Uno, will be attending IPBC Asia 2026, taking place from 17-19 November 2026 in Tokyo, Japan. The event is one of …

Event details

HGF Recognised in the Chambers and Partners UK 2027 Guide

HGF is proud to announce that we have once again been recognised in the Chambers and Partners UK 2027 Guide, with outstanding rankings for both the firm and individual practitioners …

Read article
Event - 4th November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Event details